Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse modelsDIABETOLOGIAIF10.22022-11-211OAAI
A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic SyndromeDIABETESIF7.52018-02-2626OAAI
Treatment of Diabetic Rats With Insulin or a Synthetic Insulin Receptor Agonist Peptide Leads to Divergent Metabolic ResponsesDIABETESIF7.52014-10-145OAAI
Brain glycogen and its role in supporting glutamate and GABA homeostasis in a type 2 diabetes rat modelNEUROCHEMISTRY INTERNATIONALIF42012-02-0160PREAI
Receptor-isoform-selective insulin analogues give tissue-preferential effectsBIOCHEMICAL JOURNALIF4.32011-11-2839OAAI
Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptorDIABETES OBESITY & METABOLISMIF5.72010-06-2428PREAI
Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasisJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISMIF4.52010-04-2878OAAI
Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim testEUROPEAN JOURNAL OF PHARMACOLOGYIF4.71996-04-01101OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向